Lectenz Bio in News and Media

September 1, 2017 0 0

The National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio a second SBIR Phase I to apply the...

August 1, 2017 0 0

Lectenz Bio receives a U01 from the NIH Common Fund Glycoscience program to further develop GlycoSenseTM technology. Lectenz Bio receives an SBIR...

June 19, 2017 0 0

Dr. Lori Yang, co-Founder and CSO of Lectenz Bio, will be a featured panelist at San Diego Startup Week on June 20th. Dr. Yang will share about...

June 16, 2017 0 0

Prof. Robert J. Woods, President and co-Founder, and collaborators reported in PLoS Pathogens on Thursday, June 15th that three mutations switch...

March 28, 2017 0 0

The Lectenz Bio team is excited to announce the approval of its first patent for a carbohydrate-like small molecule inhibitor. This expands the...

March 8, 2017 0 0

Lectenz Bio’s Chief Scientific Officer and co-founder Lori Yang was recently interviewed by JLabs for her work on International...

October 12, 2016 0 0

Lectenz Bio team was selected to participate as semi-finalists for the 2016 Thermo Fisher Scientific Innovation Day. This unique program is set up...

September 13, 2016 0 0

RESI (Redefining Early Stage Investments) seeks to bring together early stage life science companies with strategic investors in order to create...

June 23, 2016 0 0

Lectenz Bio received Best Poster recognition at the 2016 Biomanufacturing Technology Summit. The team presented their work on the bioprocess...

January 28, 2016 0 0

Georgia Bio (GaBio) announced Lectenz Bio’s CEO, Kausar Samli, as a recipient of the Emerging Leader Award for 2016. The award celebrates...

December 8, 2015 0 0

The Lectenz Bio participated in the 2015-2016 Advanced Commercialization Track in the NIH Commercialization Accelerator Program (CAP). The NIH CAP...

June 15, 2015 0 0

Lectenz Bio represented the state of Georgia at the BIO 2015 Summit in Philadelphia. This conference focuses on bringing together biotech’s top...